Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could family and community support help slow cognitive decline?

NCT ID NCT07703267

Not yet recruiting Disease control Sponsor: Anhui Medical University Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This trial tests whether an 8-week community-family mutual support program can improve cognitive function and social support in adults aged 60 and older with mild cognitive impairment (MCI). Participants receive cognitive training, health education, family support, and group activities alongside routine community care. The study aims to see if this social-support approach can help maintain mental function and daily living skills.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an 8-week community-family mutual support program including cognitive training, health education, family support, and group activities
What this could lead to
If effective, this program could offer a low-cost, community-based way to slow cognitive decline and improve quality of life for older adults with mild cognitive impairment.
What could go wrong
This is a small, early-stage study with 70 participants, so results may not apply broadly. The intervention is complex and relies on family and community engagement, which may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MILD COGNITIVE IMPAIRMENT (MCI)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.